Inhibitory effect of nogalamycin on tumour promotion.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D003630:Daunorubicin / Q000031:analogs & derivatives*; D005260:Female; D051379:Mice; D009374:Neoplasms, Experimental / Q000517:prevention & control; D009621:Nogalamycin / Q000494:pharmacology*; D010212:Papilloma / Q000517:prevention & control; D012878:Skin Neoplasms / Q000517:prevention & control; D013755:Tetradecanoylphorbol Acetate
D002273:Carcinogens; D015127:9,10-Dimethyl-1,2-benzanthracene; D009621:Nogalamycin; D013755:Tetradecanoylphorbol Acetate; D003630:Daunorubicin